World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
71
Citations
19013
World Ranking
19983
National Ranking
9954

Overview

Janet L. Davis is affiliated with the University of Miami in the United States and has a significant body of work primarily in the field of Medicine, with a strong emphasis on Ophthalmology. Their research spans 139 publications in Medicine, including 83 in Ophthalmology, supplemented by studies in Molecular Biology, Radiology, Nuclear Medicine and Imaging, Rheumatology, and Epidemiology.

Their scholarly output includes contributions to several major publication venues, notably the American Journal of Ophthalmology with 10 publications, American Journal of Ophthalmology Case Reports with 7, Ophthalmology and Ophthalmology Retina each with 4, and Ocular Immunology and Inflammation with 4.

Key research topics covered by Janet L. Davis include:

  • Ocular Diseases and Behçet's Syndrome
  • Retinal and Optic Conditions
  • Retinal Diseases and Treatments
  • Retinal Development and Disorders
  • Vasculitis and related conditions
  • Ocular Infections and Treatments
  • Intraocular Surgery and Lenses

Frequently collaborating with other researchers, Janet L. Davis has strong co-authorship ties with Byron L. Lam, Marc D. de Smet, Douglas A. Jabs, Justine R. Smith, and Rupesh Agrawal.

Selected recent papers by Janet L. Davis include:

  • Initial results from a first-in-human gene therapy trial on X-linked retinitis pigmentosa caused by mutations in RPGR, 2020, Nature Medicine
  • Collaborative Ocular Tuberculosis Study Consensus Guidelines on the Management of Tubercular Uveitis-Report 1, 2020, Ophthalmology
  • Collaborative Ocular Tuberculosis Study Consensus Guidelines on the Management of Tubercular Uveitis-Report 2, 2020, Ophthalmology
  • Changes in Retinal Sensitivity Associated With Cotoretigene Toliparvovec in X-Linked Retinitis Pigmentosa With RPGR Gene Variations, 2023, JAMA Ophthalmology
  • Retinal Vasculitis After Intravitreal Pegcetacoplan: Report From the ASRS Research and Safety in Therapeutics (ReST) Committee, 2023, Journal of VitreoRetinal Diseases

Best Publications

  • Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt's macular dystrophy: follow-up of two open-label phase 1/2 studies

    Steven D. Schwartz;Carl D. Regillo;Byron L. Lam;Dean Eliott

  • An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration.

    Anne E. Fung;Geeta A. Lalwani;Philip J. Rosenfeld;Sander R. Dubovy

  • A variable-dosing regimen with intravitreal ranibizumab for neovascular age-related macular degeneration: year 2 of the PrONTO Study.

    Geeta A. Lalwani;Philip J. Rosenfeld;Anne E. Fung;Sander R. Dubovy

  • Short-term safety and efficacy of intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration.

    Ryan M. Rich;Philip J. Rosenfeld;Carmen A. Puliafito;Sander R. Dubovy

  • Primary Vitreoretinal Lymphoma: A Report from an International Primary Central Nervous System Lymphoma Collaborative Group Symposium

    Chi Chao Chan;James L. Rubenstein;Sarah E. Coupland;Janet L. Davis

  • Ocular complications of pediatric uveitis.

    Krista D. Rosenberg;William J. Feuer;Janet L. Davis

  • Culture-proven endogenous endophthalmitis: clinical features and visual acuity outcomes

    Vivian Schiedler;Ingrid U. Scott;Harry W. Flynn;Janet L. Davis

  • Treatment outcomes in a 10-year study of endogenous fungal endophthalmitis.

    Thomas F Essman;Harry W Flynn;William E Smiddy;Roy D Brod

  • Decrease in the risk of bilateral acute retinal necrosis by acyclovir therapy.

    David A. Palay;Paul Sternberg;Janet Davis;Hilel Lewis

  • Initial results from a first-in-human gene therapy trial on X-linked retinitis pigmentosa caused by mutations in RPGR

    Jasmina Cehajic-Kapetanovic;Kanmin Xue;Cristina Martinez-Fernandez de la Camara;Anika Nanda

  • Acute-onset endophthalmitis after clear corneal cataract surgery (1996-2005). Clinical features, causative organisms, and visual acuity outcomes.

    Geeta A. Lalwani;Harry W. Flynn;Ingrid U. Scott;Carolyn M. Quinn

  • Gene Therapy for Leber Hereditary Optic Neuropathy: Initial Results.

    William J. Feuer;Joyce C. Schiffman;Janet L. Davis;Vittorio Porciatti

  • Guidance on Noncorticosteroid Systemic Immunomodulatory Therapy in Noninfectious Uveitis: Fundamentals Of Care for UveitiS (FOCUS) Initiative

    Andrew D. Dick;Andrew D. Dick;Andrew D. Dick;James T. Rosenbaum;Hassan A. Al-Dhibi;Rubens Belfort

  • ENDOPHTHALMITIS AFTER INTRAVITREAL ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR ANTAGONISTS: A Six-Year Experience at a University Referral Center

    Andrew A. Moshfeghi;Philip J. Rosenfeld;Harry W. Flynn;Stephen G. Schwartz

  • Diagnostic testing of vitrectomy specimens.

    Janet L. Davis;Daniel M. Miller;Phillip Ruiz

  • Endogenous Fungal Endophthalmitis: Causative Organisms, Management Strategies, and Visual Acuity Outcomes

    Ahila Lingappan;Charles C. Wykoff;Thomas A. Albini;Darlene Miller

  • Polymerase chain reaction analysis of aqueous and vitreous specimens in the diagnosis of posterior segment infectious uveitis.

    Thomas W. Harper;Darlene Miller;Joyce C. Schiffman;Janet L. Davis

  • Idiopathic Retinal Vasculitis, Aneurysms, and Neuro-retinitis

    T. S. Chang;G. W. Aylward;J. L. Davis;W. F. Mieler

  • Iritis and hypotony after treatment with intravenous cidofovir for cytomegalovirus retinitis.

    Janet L. Davis;Ibrahim Taskintuna;William R. Freeman;David V. Weinberg

  • Mutations Conferring Ganciclovir Resistance in a Cohort of Patients with Acquired Immunodeficiency Syndrome and Cytomegalovirus Retinitis

    Douglas A. Jabs;Douglas A. Jabs;Barbara K. Martin;Michael S. Forman;J. P. Dunn

Frequent Co-Authors

Harry W. Flynn
Harry W. Flynn University of Miami
William E. Smiddy
William E. Smiddy University of Miami
William J. Feuer
William J. Feuer University of Miami
Douglas A. Jabs
Douglas A. Jabs Johns Hopkins University School of Medicine
Philip J. Rosenfeld
Philip J. Rosenfeld University of Miami
Robert B. Nussenblatt
Robert B. Nussenblatt National Institutes of Health
Ingrid U. Scott
Ingrid U. Scott Pennsylvania State University
Gary N. Holland
Gary N. Holland University of California, Los Angeles
Carmen A. Puliafito
Carmen A. Puliafito University of Southern California
Manfred Zierhut
Manfred Zierhut University of Tübingen

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in medicine but considering alternative or complementary healthcare paths, there are a variety of online degree and bridge programs available. If you’re aiming for a nursing career but want to avoid lengthy admissions testing, you might explore a nursing school that don't require teas. This option can streamline your entry into the nursing profession.

If you are interested in healthcare leadership, the best online healthcare administration degree programs can prepare you for management roles within hospitals, insurance companies, or medical offices—all from the convenience of online learning.

Registered nurses looking to advance their careers may consider rn to fnp bridge programs. These bridge options help RNs build on their experience to become Family Nurse Practitioners (FNPs) with expanded responsibilities and increased earning potential.

For those with a passion for wellness and nutrition, pursuing nutrition degrees online can open doors to a range of careers, from clinical settings to public health organizations. Exploring these related pathways can help you find a rewarding career in healthcare that matches your interests and educational goals.

Best Scientists Citing Janet L. Davis

Trending Scientists